alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2  CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Melissa Ladakis, certify that:  1.   I have reviewed this Quarterly Report (the Report) on Form 10-QSB of the small business issuer;  2.   Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;  3.   Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this Report;  4.   The small business issuers other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this Report is being prepared;  b) evaluated the effectiveness of the small business issuers disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and  c) disclosed in this Report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and  5.   The small business issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the small business issuers board of directors (or persons performing the equivalent functions);  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal control over financial reporting.  Date:7/31/07By:/s/Melissa LadakisMelissa LadakisSecretary, Treasurer and Director
CLOSED

UNITED STATES DISTRICT COURT

DISTRICT OF NEW JERSEY

KIMBERLEE WILLIAMS, et al.,

Plaintiffs, 

v.

BASF CATALYSTS LLC, et al.,

Defendants.

:

:

:

:

:

:

:

:

:

:

:

Civil Action No. 11-1754 (SRC)

ORDER

CHESLER, District Judge

This matter having come before the Court on several motions to dismiss the Amended

Class Action Complaint (“Amended Complaint”), identified by filing Defendants as follows: 

BASF Catalysts LLC [docket entry 83]; Cahill Gordon & Reindel LLP (f/k/a Cahill, Gordon &

Reindel), Howard G. Sloane, Ira J. Dembrow and Scott A. Martin [docket entry 80]; Arthur A.

Dornbusch II [docket entry 77]; Glen Hemstock [docket entry 78]; and Thomas D. Halket

[docket entry 79]; and, in connection with these motions, the Court also having been presented

with a motion by Public Justice, P.C. for leave to appear as amicus curiae and file an amicus brief

[docket entry 97]; and Plaintiffs having opposed the motions to dismiss; and the Court having

considered the motions on the papers submitted and without oral argument, pursuant to Federal

Rule of Civil Procedure 78; and for the reasons expressed by the Court in the Opinion filed

herewith, 

IT IS on this 12 day of December, 2012, th

Case 2:11-cv-01754-SRC-CLW Document 130 Filed 12/12/12 Page 1 of 2 PageID: 4024
ORDERED that the motion by Public Justice for leave to appear as amicus curiae

[docket entry 97] be and hereby is DENIED; and it is further 

ORDERED that the motions to dismiss the Amended Complaint [docket entries 77, 78,

79, 80 and 83] be and hereby are GRANTED; and it is further

ORDERED that the motion to strike class allegations from the Amended Complaint and

deny class certification [docket entry 81] be and hereby is DISMISSED AS MOOT; and it is

further

ORDERED that the claims set forth in the AMENDED COMPLAINT be and hereby

are DISMISSED WITH PREJUDICE.

 s/Stanley R. Chesler 

STANLEY R. CHESLER

United States District Judge

2

Case 2:11-cv-01754-SRC-CLW Document 130 Filed 12/12/12 Page 2 of 2 PageID: 4025
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 06-6597

PATRICK EUGENE ALLRED, Petitioner - Appellant, versus BONNIE BOYETTE, Respondent - Appellee. Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. Terrence W. Boyle, District Judge. (5:05-hc-00232-BO) Submitted: October 20, 2006 Decided: November 16, 2006 Before TRAXLER, GREGORY, and DUNCAN, Circuit Judges. Dismissed by unpublished per curiam opinion. Charles R. Brewer, Asheville, North Carolina, for Appellant. Mary Carla Hollis, NORTH CAROLINA DEPARTMENT OF JUSTICE, Raleigh, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Patrick Eugene Allred seeks to appeal the district court’s order denying relief on his 28 U.S.C. § 2254 (2000) petition. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. Miller-El v. Cockrell , 537 U.S. 322, 336-38 (2003); Slack v. McDaniel , 529 U.S. 473, 484 (2000); Rose v. Lee , 252 F.3d 676, 683-84 (4th Cir. 2001). We have independently reviewed the record and conclude that Allred has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process. DISMISSED
[Federal Register Volume 74, Number 16 (Tuesday, January 27, 2009)]
[Notices]
[Page 4753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1654]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Ancillary Studies in 
Immunomodulation Clinical Trials.
    Date: February 17, 2009.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, DHHS/
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, 301-402-7098, <a href="/cdn-cgi/l/email-protection#b7c7d6dac4c3d6d3f7d9ded6ded399d9dedf99d0d8c1"><span class="__cf_email__" data-cfemail="dfafbeb2acabbebb9fb1b6beb6bbf1b1b6b7f1b8b0a9">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E9-1654 Filed 1-26-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CNP_Exhibit 10(s)_12.31.2012






Exhibit 10(s) 


CenterPoint Energy, Inc.
Summary of Certain Compensation Arrangements
of the Non-Executive Chairman of the Board


The following is a summary of certain compensation arrangements of Milton Carroll, the non-executive chairman of the board of directors of CenterPoint Energy, Inc. (the “Company”), effective April 22, 2010. Such compensation arrangements are in addition to the normal retainers paid to directors and committee chairmen of the Company's board of directors (which Milton Carroll shall continue to receive while a non-employee director). For additional information regarding the compensation of the non-employee directors, please read the definitive proxy statement relating to the Company's 2013 annual meeting of shareholders filed pursuant to Regulation 14A. 
		
	•
	Supplemental retainer of $30,000 per month, payable on the last day of each month, commencing on June 30, 2010 and continuing each month thereafter until the earlier of May 31, 2013 or the termination of Milton Carroll's service as non-executive Chairman of the Board (the “Payment Period”);




		
	•
	Additional cash awards on June 1, 2010, June 1, 2011 and June 1, 2012 (each such award, a “Cash Award”) in an amount equal to the product of (i) 25,000 and (ii) the closing sales price per share of the Company's common stock, par value $0.01 per share (the “Common Stock”), on the consolidated transaction reporting system for the New York Stock Exchange on the respective award date or, if there have been no such sales so reported on that date, on the date immediately preceding the respective award date on which such a sale was so reported;




		
	•
	An option, on or prior to the award date of a Cash Award, to elect to receive 25,000 fully vested shares of Common Stock in lieu of any Cash Award (subject to the holding period and resale restrictions contained in Rule 144 under the Securities Act of 1933, as amended); and




		
	•
	Certain administrative support during the Payment Period including (a) an office at the Company's Houston headquarters and (b) a full-time executive assistant.
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________
No. 1D 19

- 1045

_____________________________ C HARLES J ONES ,
Petitioner
,

v.

S TATE OF F LORIDA , Respondent

.

_____________________________

Petition for Belated Appeal

— Original Jurisdiction

.

April 17, 2019

P ER C URIAM

. The petition for belated appeal is denied.

L EWIS , W ETHERELL , and J AY , JJ., concur

.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________

Charles Jones, pro se
, Petitioner

.2 Ashley Moody, Attorney General, Tallahassee
, for Respondent

.
UNITED STATES DISTRICT COURT 

DISTRICT OF NEW JERSEY 

INTERNATIONAL TRANSPORT 

MANAGEMENT CORPORATION, and 

OCEAN NAVIGATOR EXPRESS LINE, 

Plaintiff,

- against -

BROOKS FITCH APPAREL GROUP, LLC and 

JOSEPH E. SAFDIEH,

Defendants.

Civil Action No: 11-1921 (ES) 

NOTICE OF APPEAL TO THE U.S. 

COURT OF APPEALS FOR THE 

THIRD CIRCUIT

Notice is hereby given that defendants Brooks Fitch Apparel Group, LLC and Joseph E. 

Safdieh appeal to the United States Court of Appeals for the Third Circuit from the Judgment of 

the United States District Court, District of New Jersey, dated January 7, 2022 and entered in this 

action on January 11, 2022.

Dated: February 10, 2022

OFECK & HEINZE, LLP

Attorneys for Defendants-Appellants

By: __Mark F. Heinze______

Mark F. Heinze

85 Main Street, Suite 204

Hackensack, NJ 07604

Tel. 201-488-9900

Fax. 201-488-4475

mark@ofeckheinze.com

Case 2:11-cv-01921-ES-JSA Document 252 Filed 02/10/22 Page 1 of 2 PageID: 8840
INTERNATIONAL TRANSPORT 

MANAGEMENT CORPORATION, and 

OCEAN NAVIGATOR EXPRESS LINE, 

Plaintiff,

- against -

BROOKS FITCH APPAREL GROUP, LLC and 

JOSEPH E. SAFDIEH,

Defendants.

Civil Action No: 11-1921 (ES)

Judge: Hon. Esther Salas, USDJ

PROOF OF SERVICE 

On February 10, 2022, I served the within Notice of Appeal on counsel for plaintiff via 

ECF and first class mailing at the addresses noted below. I declare (or certify, verify, or state) 

under penalty of perjury under the laws of the United States of America that the foregoing is true 

and correct. 

Executed on February 10, 2022

 __Mark F. Heinze______ 

 Mark F. Heinze

Address of Service:

OWEN DUFFY, ESQ.

LAW OFFICE OF OWEN F. DUFFY

5 Penn Plaza, 19th Fl., 

New York, N.Y. 10001

Attorney for Plaintiffs 

GEORGE EDMUND MURRAY

961 Mercer Road 

Princeton, NJ 08540 

917-539-7364 

888-742-2637 (fax) 

gemurraylaw@aol.com

Attorney for Plaintiffs 

Case 2:11-cv-01921-ES-JSA Document 252 Filed 02/10/22 Page 2 of 2 PageID: 8841
[Federal Register Volume 74, Number 127 (Monday, July 6, 2009)]
[Notices]
[Pages 31954-31955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15932]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The applications also will be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States. 
Additional information on all bank holding companies may be obtained 
from the National Information Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than July 31, 2009.
    A. Federal Reserve Bank of New York (Ivan Hurwitz, Bank 
Applications Officer) 33 Liberty Street, New York, New York 10045-0001:
    1. Haven Bancorp, MHC and Haven Bancorp, Inc., both of Hoboken, New 
Jersey; to become bank holding companies by acquiring 100 percent of

[[Page 31955]]

the voting shares of Haven Savings Bank, Hoboken, New Jersey.

    Board of Governors of the Federal Reserve System, July 1, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9-15932 Filed 7-2-09; 8:45 am]
BILLING CODE 6210-01-S
Exhibit 99.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

I,
Grant Miller, certify that:

To
the best of my knowledge and belief, the Transition Report on Form 10-KSB filed with the Securities and Exchange Commission on November 21, 2002 by USA Broadband, Inc.
and to which this certification is appended (the "Periodic Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and the information contained
in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of USA Broadband, Inc.

|Date: November 21, 2002 |  | /s/GRANT MILLERGrant Miller
Principal Executive Officer
|----------------------- |  | -------------------------------------------------------

---

QuickLinks
PRK-EX10.2(b)-2012.12.31-10K






Exhibit 10.2(b)


Schedule identifying Split-Dollar Agreements covering executive officers 
(or former executive officers) or employees of The Park National Bank 
who are also directors or executive officers (or former executive officers 
who are “named executive officers” for purposes of Item 402 of SEC 
Regulation S-K) of Park National Corporation, which Split-Dollar 
Agreements are identical to the Split-Dollar Agreement, dated
May 17, 1993, between William T. McConnell and The Park National Bank


The following individuals entered into the Split-Dollar Agreements identified below, which Split-Dollar Agreements are identical to the Split-Dollar Agreement, dated May 17, 1993, between William T. McConnell, Chairman of the Executive Committee of the Board of Directors and a director of each of Park and The Park National Bank (“Park National Bank”), and Park National Bank, filed as Exhibit 10(f) to Park's Annual Report on Form 10-K for the fiscal year ended December 31, 1993 (File No. 0-18772):


	
					
	Name and Positions Held With Park and Park National Bank
	 
	Date of Split- Dollar Agreement
	 
	Subsidiary of Park which is Party to Split-Dollar Agreement

	 
	 
	 
	 
	 

	C. Daniel DeLawder - Chairman of the Board, Chief Executive Officer and a director of each of Park and Park National Bank
	 
	May 26, 1993
	 
	Park National Bank

	 
	 
	 
	 
	 

	David L. Trautman - President, Secretary and a director of Park; President and a director of Park National Bank
	 
	September 23, 1993
	 
	Park National Bank

	 
	 
	 
	 
	 

	John W. Kozak - Former Chief Financial Officer of Park; Former Senior Vice President and Chief Financial Officer and a former director of Park National Bank (1)
	 
	June 2, 1993
	 
	Park National Bank






(1)    Effective December 19, 2012, Mr. Kozak retired from his positions as Chief Financial Officer of Park and as Senior Vice President, Chief Financial Officer and a director of Park National Bank.  As of the filing date of the Annual Report on Form 10-K of Park for the fiscal year ended December 31, 2012, Mr. Kozak is a “named executive officer” for purposes of Item 402 of SEC Regulation S-K.
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly report of China Pharma Holdings, Inc. (the
"Company")  on 10-KSB for the period  ended  December 31, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Xinhua
Wu,  Chief  Financial  Officer of the  Company,  certify,  pursuant to 18 U.S.C.
section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully  complies  with the  requirements  of section  13(a)or
15(d) of the Securities and Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.

     A signed  original of this  written  statement  required by Section 906 has
been  provided  to China  Pharma  Holdings,  Inc.  and will be retained by China
Pharma Holdings, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.


                                                         Date: March 26, 2007

                                                         By: /s/ Xinhua Wu
                                                                 Xinhua Wu
                                                         Chief Financial Officer